We analyzed hereditary CHEK2 variants in the entire coding sequence of the CHEK2 gene in large group of NHL patients, and found that CHEK2 variants could modify the risk and clinical course of NHL. The gene discussed is CHEK2; the disease is non-Hodgkin lymphoma.